Chloroquine resistance before and after its withdrawal in Kenya
<p>Abstract</p> <p>Background</p> <p>The spread of resistance to chloroquine (CQ) led to its withdrawal from use in most countries in sub-Saharan Africa in the 1990s. In Malawi, this withdrawal was followed by a rapid reduction in the frequency of resistance to the poin...
Main Authors: | Marsh Kevin, Sasi Philip, Kokwaro Gilbert, Ward Steve, Kiara Steven M, Abdirahman Abdi, Ochong Edwin, Mwai Leah, Borrmann Steffen, Mackinnon Margaret, Nzila Alexis |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-05-01
|
Series: | Malaria Journal |
Online Access: | http://www.malariajournal.com/content/8/1/106 |
Similar Items
-
Chloroquine resistance before and after its withdrawal in Kenya.
by: Mwai, L, et al.
Published: (2009) -
In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.
by: Mwai, L, et al.
Published: (2009) -
Molecular monitoring of the Leu-164 mutation of dihydrofolate reductase in a highly sulfadoxine/pyrimethamine-resistant area in Africa.
by: Ochong, E, et al.
Published: (2003) -
The MSPDBL2 codon 591 polymorphism is associated with lumefantrine in vitro drug responses in Plasmodium falciparum isolates from Kilifi, Kenya.
by: Ochola-Oyier, L, et al.
Published: (2014) -
Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet?
by: Nzila, A, et al.
Published: (2005)